Insulin glargine and Pyridostigmine Extended-Release Tablets
Determining the interaction of Insulin glargine and Pyridostigmine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: pyridostigmine
Brand name: Mestinon, Mestinon Timespan, Regonol
Synonyms: Pyridostigmine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Pyridostigmine Injection
- Insulin glargine-Pyridostigmine Liquid
- Insulin glargine-Pyridostigmine Oral Solution
- Insulin glargine-Pyridostigmine Tablets
- Insulin glargine-Pyridoxine
- Insulin glargine-Pyridoxine (Vitamin B6) Capsules and Tablets
- Pyridostigmine Extended-Release Tablets-Insulin Glargine (U-100) Cartridge Systems and Pens
- Pyridostigmine Extended-Release Tablets-Insulin Glargine (U-100) Vials
- Pyridostigmine Extended-Release Tablets-Insulin Glargine (U-300) Pens
- Pyridostigmine Extended-Release Tablets-Insulin glargine and lixisenatide
- Pyridostigmine Extended-Release Tablets-Insulin glargine and lixisenatide Subcutaneous
- Pyridostigmine Extended-Release Tablets-Insulin glargine, recombinant Subcutaneous